News
On Aug. 17, the U.S. Food and Drug Administration (FDA) approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell…
Nurses’ knowledge of postpartum complications needs improvement
A study in MCN notes that most nurses who care for women during the postpartum period aren’t current on the rates and timing of…
Probiotics may prevent sepsis in infants
A randomized, double-blind, placebo-controlled trial reported in Nature notes that combining a probiotic with fructo-oligosaccharide significantly reduces sepsis and mortality in newborns in rural…
Unique Nursing Specialties You May Not Be Aware Of
There are so many opportunities in the nursing field that can move your career in unexpected ways and into different places. Here are some…
Nurse Wins Prize For Research On Benefits Of Faster Tuberculosis Testing
There was a time when Chenai Mathabire read Vogue, watched beauty pageants on TV and fantasized about being a supermodel. Today she helps the…
Calcium could be the answer to C. difficile infection
Scientists have found that a dangerous bacterium capable of causing serious gut infections is triggered by excess calcium in its environment, but the triggering…
FDA approves treatment for chronic graft versus host disease
August 3, 2017 – The U.S. Food and Drug Administration today expanded the approval of Imbruvica (ibrutinib) for the treatment of adult patients with…
FDA announces new plan to address nicotine consumption
Protecting American Families: Comprehensive Approach to Nicotine and Tobacco Remarks by Scott Gottlieb, M.D. / Commissioner of Food and Drug Administration July 28, 2017 / White…
FDA clears first neonatal MRI system
On July 20, the U.S. Food and Drug Administration (FDA) cleared Embrace Neonatal MRI System, the first magnetic resonance imaging (MRI) device specifically for…
FDA approves new treatment for hepatitis C
On July 18, the U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without…
Detecting long-term concussion in athletes
Researchers develop method that could one day be used in brain trauma lawsuits Lawyers representing both sides in concussion lawsuits against sports leagues may…
New treatment for sickle cell disease approved by the FDA
First approval for this rare blood disorder in nearly 20 years. For Immediate Release: July 7, 2017 – via fda.gov The U.S. Food and Drug…
FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia
On Aug. 17, the U.S. Food and Drug Administration (FDA) approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or…
Nurses’ knowledge of postpartum complications needs improvement
A study in MCN notes that most nurses who care for women during the postpartum period aren’t current on the rates and…
Probiotics may prevent sepsis in infants
A randomized, double-blind, placebo-controlled trial reported in Nature notes that combining a probiotic with fructo-oligosaccharide significantly reduces sepsis and mortality in newborns…
Unique Nursing Specialties You May Not Be Aware Of
There are so many opportunities in the nursing field that can move your career in unexpected ways and into different places. Here…
Nurse Wins Prize For Research On Benefits Of Faster Tuberculosis Testing
There was a time when Chenai Mathabire read Vogue, watched beauty pageants on TV and fantasized about being a supermodel. Today she…
Calcium could be the answer to C. difficile infection
Scientists have found that a dangerous bacterium capable of causing serious gut infections is triggered by excess calcium in its environment, but…
FDA approves treatment for chronic graft versus host disease
August 3, 2017 – The U.S. Food and Drug Administration today expanded the approval of Imbruvica (ibrutinib) for the treatment of adult…
FDA announces new plan to address nicotine consumption
Protecting American Families: Comprehensive Approach to Nicotine and Tobacco Remarks by Scott Gottlieb, M.D. / Commissioner of Food and Drug Administration July 28,…
FDA clears first neonatal MRI system
On July 20, the U.S. Food and Drug Administration (FDA) cleared Embrace Neonatal MRI System, the first magnetic resonance imaging (MRI) device…
FDA approves new treatment for hepatitis C
On July 18, the U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes…
Detecting long-term concussion in athletes
Researchers develop method that could one day be used in brain trauma lawsuits Lawyers representing both sides in concussion lawsuits against sports…
New treatment for sickle cell disease approved by the FDA
First approval for this rare blood disorder in nearly 20 years. For Immediate Release: July 7, 2017 – via fda.gov The U.S. Food…
Poll




NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.












